← All organizations

Orexo AB

For profitWebsite ↗

Also known as: Orexa BV | Orexo AB | OREXO US INC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

Aug 1, 2023

Timeline

1990s

Jul 1, 1995
Orexo AB— Founded

2000s

Nov 23, 2007
Biolipox AB— Acquired
Feb 23, 2009
PharmaKodex— Acquired

2010s

Jul 3, 2013
buprenorphine— Marketing Organization
Jul 3, 2013
buprenorphine— NDA Secondary Org

Drugs by trial phase (6 distinct, 7 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

naloxone

Phase 2 (2 own, 1 via acquisition)

Indications

Studied for

Marketed drugs (2)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (7)

NCT05923086Lead sponsorPhase 2Aug 1, 2023
NCT01908842Lead sponsorPhase 3Aug 1, 2013
NCT01903005Lead sponsorPhase 4Jul 1, 2013
NCT01848054Lead sponsorPhase 3Jun 1, 2013
NCT01315886Lead sponsorPhase 4Feb 21, 2011
NCT01315886Study chairPhase 4Feb 21, 2011
NCT00758446CollaboratorPhase 2Sep 1, 2008

Details

Founded: Stockholm, SE Jul 1, 1995
Last known activity: Aug 1, 2023

Notes

Acquired PharmaKodex 23 Feb 2009 Acquired Biolipox 23 Nov 2007